Latest Industry Insights
Industry Insight
New Frontiers in the Cannabis Testing Industry
Driven by the introduction and evolution of cannabis contaminant testing, and regulations in many different states, companies in the cannabis testing industry are constantly innovating and creating new methods and applications for use in testing laboratories. We spoke to Anthony Macherone to learn more about some of the major trends and potential future themes in the cannabis testing industry.
Industry Insight
A Path to Better Plant-Based Foods
With demands for food rising as the population continues to expand, and the ever-present threat of climate change, scientists are looking for innovative ways to feed society without adding to the planet’s burdens. Plant-based foods are one area of great interest to meet this need.
Industry Insight
Make Data Work for You in the Race To Manufacture Effective Vaccines
It’s imperative that scientists and leaders in the COVID-19 vaccine development space have good data management practices to ensure the quality of data and to recue the time-to-market now, and in the future. In this article, we explore how to make data work for you when manufacturing an effective vaccine.
Industry Insight
Accelerated Screen Identifies 25 Existing Drugs Capable of Disrupting SARS-CoV-2 Cell Entry
A team from the National Center for Advancing Translational Sciences (NCATS) has screened existing drug compounds that have already passed through the entire drug development pipeline, to determine if any can disrupt the interaction between the SARS-CoV-2 spike protein and the host’s angiotensin converting enzyme 2 (ACE2) receptor.
Industry Insight
Looking Beyond the Spike Protein for SARS-CoV-2 Vaccine Design
Biotech company COVAXX is developing a COVID-19 vaccine using a multi-antigen peptide platform, which not only targets the infamous SARS-CoV-2 Spike (S) protein but also targets other parts of the virus to enhance the immune response. Technology Networks spoke with Mei Mei Hu, co-founder of COVAXX, to learn more about the vaccine platform and the preclinical data that has been obtained for UB-612.
Industry Insight
Antiviral Conjugates – A Novel Treatment and Prevention Strategy for Viral Diseases Including COVID-19
Infectious diseases remain a major health threat. The ongoing evolution of viral variants makes it likely that emerging infections will continue to occur – highlighting the need to develop new therapeutic and preventive approaches. Jeff Stein, PhD, President and CEO at Cidara Therapeutics tells Technology Networks more about a novel antiviral strategy they have developed called antiviral conjugates.
Industry Insight
Engineering Innovative CAR T-Cell Therapy Candidates for Cancer
Technology Networks recently had the pleasure of speaking with Celyad Oncology’s CEO Filippo Petti. In this interview, Petti discusses key immunotherapy advances, highlights the two main CAR T-cell therapy approaches and elaborates on the company’s “off-the-shelf” CAR T cells.
Industry Insight
A New SARS-CoV-2 Descriptive Diagnostic Test – What Makes This Assay Different to Others?
Clear Labs is a company focused on the latest technologies in molecular testing, machine learning, automation and bioinformatics – it develops fully automated next-generation sequencing and in vitro diagnostics solutions. Technology Networks had the pleasure of speaking with ClearLabs’ CEO Sasan Amini, to learn more about the company’s NGS-based COVID test, Clear Dx™.
Industry Insight
Exploring Plant-Based Bioreactors for Developing COVID-19 Therapeutics and Vaccines
Technology Networks recently spoke with iBio’s CEO and Chairman of the Board Thomas Isett, to learn more about the company’s efforts to develop a novel COVID-19 therapeutic called ACE2-Fc, as well as two vaccine candidates IBIO-200 and IBIO-201.
Industry Insight
Next-Generation Sequencing: Tracking the Spread and Evolution of SARS-CoV-2
This article explores how next-generation sequencing (NGS) is being used to help track the spread and evolution of SARS-CoV-2, including pinpoint the different lineages of the virus and identifying patterns of its movement both globally as well as locally.
Advertisement